BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

The Biotechnology and Biological Sciences Research Council (BBSRC) has allocated £250M as the first phase of five year strategic investment programmes. This includes 26 strategic science programmes and 14 key national research capabilities, to be delivered by eight of the UK's world-leading bioscience research institutes and their university partners.

The investment will help the UK to meet challenges such as sustainably feeding the growing world population, finding alternatives to dwindling fossil fuels and supporting an ageing society to remain healthy for longer.

Commenting on the funding, Minister for Universities and Science, David Willetts said: "This £250 million investment from BBSRC for the first phase of major five year research programmes will sustain excellent science at some of the UK's leading institutes and universities. This will drive growth, support highly skilled jobs and keep the UK at the very forefront of bioscience, with benefits ranging from healthcare to energy and global food security."

The Minister made the announcement in a speech during a visit to see the progress being made in the development of the Babraham Research Campus. The campus, a BBSRC National Research and Innovation Campus, is home to the Babraham Institute, one of the institutes in receipt of today's funding.

The institutes receiving funding have a vital role in supporting BBSRC's mission to further scientific knowledge to promote economic growth and job creation in important sectors such as food, farming, renewables and pharmaceuticals. The grants will support research, key national scientific infrastructure, knowledge exchange, public engagement and institute development.

Professor Douglas Kell, BBSRC Chief Executive, said: "By almost all measures the UK has the world's best bioscience research base. BBSRC's strategic funding of institutes with distinct missions and unique national facilities is one of the reasons we achieve this. However, being the best doesn't mean much unless you make a difference in the world. Through their close links with industry and policy makers, and through engaging the public, the institutes are at the forefront of translating fundamental bioscience into products, services and advice.

"This investment is a major commitment to realising the potential of a bio-based economy in the UK. This is only possible through a sustainable, excellent fundamental research base with the right people, skills and facilities."

For the first time BBSRC's funding to the institutes has been awarded through a number of distinct strategic programme grants to each institute - and in some cases across institutes and university partners - to support five year research programmes. These have been combined with grants to support vital national research capabilities and with support for knowledge exchange, commercialisation and embedded activities, such as public engagement. The funding follows an assessment process, including independent peer review, of Institute science and programmes including knowledge exchange, public engagement and strategic HR.

Institute Strategic Programme Grants

Highlights from the 26 Institute Strategic Programme Grants (ISPGs) include:

  • Wheat pre-breeding programme at the John Innes Centre (JIC), Rothamsted Research and University partners - to build on BBSRC funding in the UK's first wheat pre-breeding programme in two decades. This programme will support the development of new varieties of wheat for farmers by broadening the number of traits available for breeding.
  • Investment in a vector-borne diseases programme at Institute for Animal Health (IAH). This programme will investigate economically important diseases of livestock that are spread by insects to improve control strategies. Diseases that will be tackled by the IAH programme include Bluetongue and African Horse Sickness.
  • Funding for a programme in integrated gut health. This programme will be led by Institute of Food Research (IFR) in partnership with two universities. It aims to improve food safety by increasing our understanding of the working of the intestinal tract and how food-borne bacteria can cause human disease.
  • Immunology programme at the Babraham Institute focused on lymphocyte homeostasis. This programme will study the role of lymphocytes in the immune system and how a regulated state is maintained by the body. This will have important implications for supporting healthy longer lives as the population ages.

National Capabilities

14 important strategic UK capabilities will be developed or maintained by this funding. These include:

  • ARK-Genomics at The Roslin Institute - funding to support this national capability in livestock animal genomics. ARK-Genomics investigates the genetic factors that influence yield, food safety, animal production and health. Outputs from the centre feed into breeding programmes of industrial partners.
  • Long-term experiments at Rothamsted Research - funding to support historic and scientifically important long-term experiments, some of which have been running continuously for over 150 years. These experiments provide important insights into the long-term sustainability of various cropping systems, particularly the impacts of intensive agriculture and environmental pollution, on sustainable agricultural systems, especially nutrient cycling, soil quality and plant diseases.
  • The Genome Analysis Centre (TGAC) will receive investment which will be used to ensure the institute can continue to deploy the latest advanced high-throughput sequencing and bioinformatics for the UK bioscience community. The funding will also support the development of new approaches to storing and handling the huge amounts of data these new techniques generate.
  • BBSRC Crop Phenotyping Centre at Institute for Biological, Environmental and Rural Sciences, Aberystwyth University (IBERS) - investment to establish a new national centre in plant phenotyping. This resource will allow researchers, industry and policymakers to access rapid analyses of different traits in plants and crops that have important industrial and agricultural uses. This will help us to overcome significant bottlenecks in current crop breeding approaches by relating desirable traits to their underpinning genetics.

Funding totals

The institutes being funded and the total amounts allocated are:

    • Institute of Biological, Environmental and Rural Sciences, Aberystwyth University (IBERS) - -13M
    • The Genome Analysis Centre (TGAC), Norwich - -19M
    • The Roslin Institute, University of Edinburgh - -23M
    • Institute for Animal Health (IAH), Pirbright - -38M
    • Institute of Food Research (IFR), Norwich - -29M
    • Babraham Institute, Cambridge - -37M
    • John Innes Centre (JIC), Norwich - -42M
    • Rothamsted Research, Harpenden - -41M

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Barcelona launches world’s first joint program on evolutionary medical genomics